Support Alert

Class 2 Medicines Recall: Ozurdex 700 micrograms intravitreal implant in applicator (Dexamethasone)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for specific batches of Ozurdex 700 micrograms intravitreal implant in applicator (Dexamethasone), manufactured by Allergan Pharmaceuticals Ireland. This is due to the possibility that a single loose silicone particle of approximately 300microns in diameter may become detached from the needle sleeve during administration of the implant and may be delivered into the eye along with the implant.


Further details of the recall, the affected batches, and action to take are available on the MHRA website.
 

Loading...